These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 17125184

  • 1. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T, Baber JC, Feher M.
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel technologies for virtual screening.
    Lengauer T, Lemmen C, Rarey M, Zimmermann M.
    Drug Discov Today; 2004 Jan 01; 9(1):27-34. PubMed ID: 14761803
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B.
    Drug Discov Today; 2008 Mar 01; 13(5-6):219-26. PubMed ID: 18342797
    [Abstract] [Full Text] [Related]

  • 7. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
    Bonachéra F, Parent B, Barbosa F, Froloff N, Horvath D.
    J Chem Inf Model; 2006 Mar 01; 46(6):2457-77. PubMed ID: 17125187
    [Abstract] [Full Text] [Related]

  • 8. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y, Schneider G.
    Nat Rev Drug Discov; 2008 Aug 01; 7(8):667-77. PubMed ID: 18636071
    [Abstract] [Full Text] [Related]

  • 9. The impact of tautomer forms on pharmacophore-based virtual screening.
    Oellien F, Cramer J, Beyer C, Ihlenfeldt WD, Selzer PM.
    J Chem Inf Model; 2006 Aug 01; 46(6):2342-54. PubMed ID: 17125178
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design and evaluation of a novel class-directed 2D fingerprint to search for structurally diverse active compounds.
    Eckert H, Bajorath J.
    J Chem Inf Model; 2006 Aug 01; 46(6):2515-26. PubMed ID: 17125192
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S, Langgård M.
    J Chem Inf Model; 2008 Mar 01; 48(3):476-88. PubMed ID: 18281962
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of data fusion methods in virtual screening: theoretical model.
    Whittle M, Gillet VJ, Willett P, Loesel J.
    J Chem Inf Model; 2006 Mar 01; 46(6):2193-205. PubMed ID: 17125164
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development and virtual screening of target libraries.
    Rognan D.
    J Physiol Paris; 2006 Mar 01; 99(2-3):232-44. PubMed ID: 16459061
    [Abstract] [Full Text] [Related]

  • 20. LigMatch: a multiple structure-based ligand matching method for 3D virtual screening.
    Kinnings SL, Jackson RM.
    J Chem Inf Model; 2009 Sep 01; 49(9):2056-66. PubMed ID: 19685924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.